These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 2548824)

  • 21. Ultrastructural characterization of a new human B lymphotropic DNA virus (human herpesvirus 6) isolated from patients with lymphoproliferative disease.
    Biberfeld P; Kramarsky B; Salahuddin SZ; Gallo RC
    J Natl Cancer Inst; 1987 Nov; 79(5):933-41. PubMed ID: 2824914
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epstein-Barr virus-associated lymphoproliferative disorders.
    Rezk SA; Weiss LM
    Hum Pathol; 2007 Sep; 38(9):1293-304. PubMed ID: 17707260
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection of T and B cell populations in some lymphoproliferative disorders.
    Herzog P; Stöckbauer P
    Czech Med; 1980; 3(4):263-70. PubMed ID: 6971744
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Persistent active herpes virus infection associated with atypical polyclonal lymphoproliferation (APL) and malignant lymphoma.
    Krueger GR; Manak M; Bourgeois N; Ablashi DV; Salahuddin SZ; Josephs SS; Buchbinder A; Gallo RC; Berthold F; Tesch H
    Anticancer Res; 1989; 9(6):1457-76. PubMed ID: 2560617
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A family study of the X-linked lymphoproliferative syndrome: evidence for a B cell defect contributing to the immunodeficiency.
    Ando I; Morgan G; Levinsky RJ; Crawford DH
    Clin Exp Immunol; 1986 Feb; 63(2):271-9. PubMed ID: 3009060
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Over-expression of c-myc oncoprotein in B lymphocytes of renal transplant recipients with lymphoproliferative disorders.
    Sabido O; Alamartine E; Barthelemy JC; Berthoux F
    Transplantation; 1993 Aug; 56(2):467-70. PubMed ID: 8395101
    [No Abstract]   [Full Text] [Related]  

  • 27. [Transfer of information from T and B lymphocytes during immune response: role of extracellular DNA].
    Anker P; Stroun M; Jachertz D; Maurice PA
    Schweiz Med Wochenschr; 1980 Oct; 110(40):1444-6. PubMed ID: 6269176
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Biology of the Epstein-Barr virus].
    Morand P; Seigneurin JM
    Ann Biol Clin (Paris); 1989; 47(7):421-7. PubMed ID: 2554764
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinico-immunological aspects of recurrent herpes simplex during vaccine therapy].
    Semenova TB; Karpovich LG; Barinskiĭ IF; Blokha VV; Kalashnikova TV
    Vestn Dermatol Venerol; 1988; (7):49-53. PubMed ID: 2851233
    [No Abstract]   [Full Text] [Related]  

  • 30. [Immunologic cell markers in lymphoproliferative diseases].
    Samoĭlova RS
    Ter Arkh; 1980; 52(9):140-9. PubMed ID: 7001662
    [No Abstract]   [Full Text] [Related]  

  • 31. Hepatitis C and B cells: induction of autoimmunity and lymphoproliferation may reflect chronic stimulation through cell-surface receptors.
    Starkebaum G; Sasso EH
    J Rheumatol; 2004 Mar; 31(3):416-8. PubMed ID: 14994381
    [No Abstract]   [Full Text] [Related]  

  • 32. The pathobiology of lymphocyte transformation.
    Taylor CR
    Pathobiol Annu; 1982; 12():65-84. PubMed ID: 6761633
    [No Abstract]   [Full Text] [Related]  

  • 33. Chronic fatigue possibly related to Epstein-Barr virus--Nevada.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1986 May; 35(21):350-2. PubMed ID: 3012308
    [No Abstract]   [Full Text] [Related]  

  • 34. Control of human B cell tumor growth in SCID mice by monoclonal anti-B cell antibodies.
    Durandy A; Brousse N; Rozenberg F; De Saint Basile G; Fischer AM; Fischer A
    Immunodeficiency; 1993; 4(1-4):73-6. PubMed ID: 8167739
    [No Abstract]   [Full Text] [Related]  

  • 35. Detection of minimal residual disease in B-lymphoproliferative disorders: a three step SSCP-PCR method.
    Miglino M; Grasso R; Pietrasanta D; Palmisano GL; Berisso G; Clavio M; Pierri I; Santini G; Canepa L; Gobbi M
    J Exp Clin Cancer Res; 2001 Mar; 20(1):95-101. PubMed ID: 11370837
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Selective immunosuppressive effects of measles virus infection.
    Pelton BK; Hylton W; Denman AM
    Clin Exp Immunol; 1982 Jan; 47(1):19-26. PubMed ID: 6284422
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of intravenous immunoglobulin and interferon-alpha on Epstein-Barr virus-induced lymphoproliferative disorder in a liver transplant recipient.
    Taguchi Y; Purtilo DT; Okano M
    Transplantation; 1994 Jun; 57(12):1813-5. PubMed ID: 8016889
    [No Abstract]   [Full Text] [Related]  

  • 38. [A new herpes virus].
    Linnavuori K; Vaheri A
    Duodecim; 1989; 105(12):1161-4. PubMed ID: 2548824
    [No Abstract]   [Full Text] [Related]  

  • 39. Monoclonal B cell proliferation in lymphoproliferative disease associated with herpes virus type 6 infection.
    Berthold F; Krueger GR; Tesch H; Hiddemann W
    Anticancer Res; 1989; 9(6):1511-8. PubMed ID: 2560619
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Patterns of Epstein-Barr virus latent and replicative gene expression in Epstein-Barr virus B cell lymphoproliferative disorders after organ transplantation.
    Rea D; Fourcade C; Leblond V; Rowe M; Joab I; Edelman L; Bitker MO; Gandjbakhch I; Suberbielle C; Farcet JP
    Transplantation; 1994 Aug; 58(3):317-24. PubMed ID: 8053055
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.